Global Brompheniramine Market Growth 2023-2029

February 2023 | 105 pages | ID: G3D3765D95F7EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Brompheniramine, is an antihistamine drug of the propylamine (alkylamine) class. It is readily available over the counter and is indicated for the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing. It is a first-generation antihistamine and one of the drugs of highest anticholinergic activity

LPI (LP Information)' newest research report, the “Brompheniramine Industry Forecast” looks at past sales and reviews total world Brompheniramine sales in 2022, providing a comprehensive analysis by region and market sector of projected Brompheniramine sales for 2023 through 2029. With Brompheniramine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Brompheniramine industry.

This Insight Report provides a comprehensive analysis of the global Brompheniramine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Brompheniramine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Brompheniramine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Brompheniramine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Brompheniramine.

The global Brompheniramine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Brompheniramine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Brompheniramine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Brompheniramine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Brompheniramine players cover Pfizer, AMAG Pharmaceuticals, PAI, USL Pharma, Watson Laboratories, Teva, Ivax Pharmaceuticals, Newtron Pharmaceuticals and Nexgen Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Brompheniramine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Oral Solution
• Tablet

Segmentation by application

• Hospital
• Drug Store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• AMAG Pharmaceuticals
• PAI
• USL Pharma
• Watson Laboratories
• Teva
• Ivax Pharmaceuticals
• Newtron Pharmaceuticals
• Nexgen Pharma
• Endo International
• Novartis
• Eon Pharma
• Merck
• Tanta Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Brompheniramine market?

What factors are driving Brompheniramine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Brompheniramine market opportunities vary by end market size?

How does Brompheniramine break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Brompheniramine Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Brompheniramine by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Brompheniramine by Country/Region, 2018, 2022 & 2029
2.2 Brompheniramine Segment by Type
  2.2.1 Oral Solution
  2.2.2 Tablet
2.3 Brompheniramine Sales by Type
  2.3.1 Global Brompheniramine Sales Market Share by Type (2018-2023)
  2.3.2 Global Brompheniramine Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Brompheniramine Sale Price by Type (2018-2023)
2.4 Brompheniramine Segment by Application
  2.4.1 Hospital
  2.4.2 Drug Store
2.5 Brompheniramine Sales by Application
  2.5.1 Global Brompheniramine Sale Market Share by Application (2018-2023)
  2.5.2 Global Brompheniramine Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Brompheniramine Sale Price by Application (2018-2023)

3 GLOBAL BROMPHENIRAMINE BY COMPANY

3.1 Global Brompheniramine Breakdown Data by Company
  3.1.1 Global Brompheniramine Annual Sales by Company (2018-2023)
  3.1.2 Global Brompheniramine Sales Market Share by Company (2018-2023)
3.2 Global Brompheniramine Annual Revenue by Company (2018-2023)
  3.2.1 Global Brompheniramine Revenue by Company (2018-2023)
  3.2.2 Global Brompheniramine Revenue Market Share by Company (2018-2023)
3.3 Global Brompheniramine Sale Price by Company
3.4 Key Manufacturers Brompheniramine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Brompheniramine Product Location Distribution
  3.4.2 Players Brompheniramine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR BROMPHENIRAMINE BY GEOGRAPHIC REGION

4.1 World Historic Brompheniramine Market Size by Geographic Region (2018-2023)
  4.1.1 Global Brompheniramine Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Brompheniramine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Brompheniramine Market Size by Country/Region (2018-2023)
  4.2.1 Global Brompheniramine Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Brompheniramine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Brompheniramine Sales Growth
4.4 APAC Brompheniramine Sales Growth
4.5 Europe Brompheniramine Sales Growth
4.6 Middle East & Africa Brompheniramine Sales Growth

5 AMERICAS

5.1 Americas Brompheniramine Sales by Country
  5.1.1 Americas Brompheniramine Sales by Country (2018-2023)
  5.1.2 Americas Brompheniramine Revenue by Country (2018-2023)
5.2 Americas Brompheniramine Sales by Type
5.3 Americas Brompheniramine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Brompheniramine Sales by Region
  6.1.1 APAC Brompheniramine Sales by Region (2018-2023)
  6.1.2 APAC Brompheniramine Revenue by Region (2018-2023)
6.2 APAC Brompheniramine Sales by Type
6.3 APAC Brompheniramine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Brompheniramine by Country
  7.1.1 Europe Brompheniramine Sales by Country (2018-2023)
  7.1.2 Europe Brompheniramine Revenue by Country (2018-2023)
7.2 Europe Brompheniramine Sales by Type
7.3 Europe Brompheniramine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Brompheniramine by Country
  8.1.1 Middle East & Africa Brompheniramine Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Brompheniramine Revenue by Country (2018-2023)
8.2 Middle East & Africa Brompheniramine Sales by Type
8.3 Middle East & Africa Brompheniramine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Brompheniramine
10.3 Manufacturing Process Analysis of Brompheniramine
10.4 Industry Chain Structure of Brompheniramine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Brompheniramine Distributors
11.3 Brompheniramine Customer

12 WORLD FORECAST REVIEW FOR BROMPHENIRAMINE BY GEOGRAPHIC REGION

12.1 Global Brompheniramine Market Size Forecast by Region
  12.1.1 Global Brompheniramine Forecast by Region (2024-2029)
  12.1.2 Global Brompheniramine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Brompheniramine Forecast by Type
12.7 Global Brompheniramine Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Brompheniramine Product Portfolios and Specifications
  13.1.3 Pfizer Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 AMAG Pharmaceuticals
  13.2.1 AMAG Pharmaceuticals Company Information
  13.2.2 AMAG Pharmaceuticals Brompheniramine Product Portfolios and Specifications
  13.2.3 AMAG Pharmaceuticals Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 AMAG Pharmaceuticals Main Business Overview
  13.2.5 AMAG Pharmaceuticals Latest Developments
13.3 PAI
  13.3.1 PAI Company Information
  13.3.2 PAI Brompheniramine Product Portfolios and Specifications
  13.3.3 PAI Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 PAI Main Business Overview
  13.3.5 PAI Latest Developments
13.4 USL Pharma
  13.4.1 USL Pharma Company Information
  13.4.2 USL Pharma Brompheniramine Product Portfolios and Specifications
  13.4.3 USL Pharma Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 USL Pharma Main Business Overview
  13.4.5 USL Pharma Latest Developments
13.5 Watson Laboratories
  13.5.1 Watson Laboratories Company Information
  13.5.2 Watson Laboratories Brompheniramine Product Portfolios and Specifications
  13.5.3 Watson Laboratories Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Watson Laboratories Main Business Overview
  13.5.5 Watson Laboratories Latest Developments
13.6 Teva
  13.6.1 Teva Company Information
  13.6.2 Teva Brompheniramine Product Portfolios and Specifications
  13.6.3 Teva Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Teva Main Business Overview
  13.6.5 Teva Latest Developments
13.7 Ivax Pharmaceuticals
  13.7.1 Ivax Pharmaceuticals Company Information
  13.7.2 Ivax Pharmaceuticals Brompheniramine Product Portfolios and Specifications
  13.7.3 Ivax Pharmaceuticals Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Ivax Pharmaceuticals Main Business Overview
  13.7.5 Ivax Pharmaceuticals Latest Developments
13.8 Newtron Pharmaceuticals
  13.8.1 Newtron Pharmaceuticals Company Information
  13.8.2 Newtron Pharmaceuticals Brompheniramine Product Portfolios and Specifications
  13.8.3 Newtron Pharmaceuticals Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Newtron Pharmaceuticals Main Business Overview
  13.8.5 Newtron Pharmaceuticals Latest Developments
13.9 Nexgen Pharma
  13.9.1 Nexgen Pharma Company Information
  13.9.2 Nexgen Pharma Brompheniramine Product Portfolios and Specifications
  13.9.3 Nexgen Pharma Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Nexgen Pharma Main Business Overview
  13.9.5 Nexgen Pharma Latest Developments
13.10 Endo International
  13.10.1 Endo International Company Information
  13.10.2 Endo International Brompheniramine Product Portfolios and Specifications
  13.10.3 Endo International Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Endo International Main Business Overview
  13.10.5 Endo International Latest Developments
13.11 Novartis
  13.11.1 Novartis Company Information
  13.11.2 Novartis Brompheniramine Product Portfolios and Specifications
  13.11.3 Novartis Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Novartis Main Business Overview
  13.11.5 Novartis Latest Developments
13.12 Eon Pharma
  13.12.1 Eon Pharma Company Information
  13.12.2 Eon Pharma Brompheniramine Product Portfolios and Specifications
  13.12.3 Eon Pharma Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Eon Pharma Main Business Overview
  13.12.5 Eon Pharma Latest Developments
13.13 Merck
  13.13.1 Merck Company Information
  13.13.2 Merck Brompheniramine Product Portfolios and Specifications
  13.13.3 Merck Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Merck Main Business Overview
  13.13.5 Merck Latest Developments
13.14 Tanta Pharmaceuticals
  13.14.1 Tanta Pharmaceuticals Company Information
  13.14.2 Tanta Pharmaceuticals Brompheniramine Product Portfolios and Specifications
  13.14.3 Tanta Pharmaceuticals Brompheniramine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Tanta Pharmaceuticals Main Business Overview
  13.14.5 Tanta Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Brompheniramine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Brompheniramine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral Solution
Table 4. Major Players of Tablet
Table 5. Global Brompheniramine Sales by Type (2018-2023) & (K Units)
Table 6. Global Brompheniramine Sales Market Share by Type (2018-2023)
Table 7. Global Brompheniramine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Brompheniramine Revenue Market Share by Type (2018-2023)
Table 9. Global Brompheniramine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Brompheniramine Sales by Application (2018-2023) & (K Units)
Table 11. Global Brompheniramine Sales Market Share by Application (2018-2023)
Table 12. Global Brompheniramine Revenue by Application (2018-2023)
Table 13. Global Brompheniramine Revenue Market Share by Application (2018-2023)
Table 14. Global Brompheniramine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Brompheniramine Sales by Company (2018-2023) & (K Units)
Table 16. Global Brompheniramine Sales Market Share by Company (2018-2023)
Table 17. Global Brompheniramine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Brompheniramine Revenue Market Share by Company (2018-2023)
Table 19. Global Brompheniramine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Brompheniramine Producing Area Distribution and Sales Area
Table 21. Players Brompheniramine Products Offered
Table 22. Brompheniramine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Brompheniramine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Brompheniramine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Brompheniramine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Brompheniramine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Brompheniramine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Brompheniramine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Brompheniramine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Brompheniramine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Brompheniramine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Brompheniramine Sales Market Share by Country (2018-2023)
Table 35. Americas Brompheniramine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Brompheniramine Revenue Market Share by Country (2018-2023)
Table 37. Americas Brompheniramine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Brompheniramine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Brompheniramine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Brompheniramine Sales Market Share by Region (2018-2023)
Table 41. APAC Brompheniramine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Brompheniramine Revenue Market Share by Region (2018-2023)
Table 43. APAC Brompheniramine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Brompheniramine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Brompheniramine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Brompheniramine Sales Market Share by Country (2018-2023)
Table 47. Europe Brompheniramine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Brompheniramine Revenue Market Share by Country (2018-2023)
Table 49. Europe Brompheniramine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Brompheniramine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Brompheniramine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Brompheniramine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Brompheniramine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Brompheniramine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Brompheniramine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Brompheniramine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Brompheniramine
Table 58. Key Market Challenges & Risks of Brompheniramine
Table 59. Key Industry Trends of Brompheniramine
Table 60. Brompheniramine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Brompheniramine Distributors List
Table 63. Brompheniramine Customer List
Table 64. Global Brompheniramine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Brompheniramine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Brompheniramine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Brompheniramine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Brompheniramine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Brompheniramine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Brompheniramine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Brompheniramine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Brompheniramine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Brompheniramine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Brompheniramine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Brompheniramine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Brompheniramine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Brompheniramine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Pfizer Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Brompheniramine Product Portfolios and Specifications
Table 80. Pfizer Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. AMAG Pharmaceuticals Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 84. AMAG Pharmaceuticals Brompheniramine Product Portfolios and Specifications
Table 85. AMAG Pharmaceuticals Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. AMAG Pharmaceuticals Main Business
Table 87. AMAG Pharmaceuticals Latest Developments
Table 88. PAI Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 89. PAI Brompheniramine Product Portfolios and Specifications
Table 90. PAI Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. PAI Main Business
Table 92. PAI Latest Developments
Table 93. USL Pharma Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 94. USL Pharma Brompheniramine Product Portfolios and Specifications
Table 95. USL Pharma Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. USL Pharma Main Business
Table 97. USL Pharma Latest Developments
Table 98. Watson Laboratories Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 99. Watson Laboratories Brompheniramine Product Portfolios and Specifications
Table 100. Watson Laboratories Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Watson Laboratories Main Business
Table 102. Watson Laboratories Latest Developments
Table 103. Teva Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 104. Teva Brompheniramine Product Portfolios and Specifications
Table 105. Teva Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Teva Main Business
Table 107. Teva Latest Developments
Table 108. Ivax Pharmaceuticals Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 109. Ivax Pharmaceuticals Brompheniramine Product Portfolios and Specifications
Table 110. Ivax Pharmaceuticals Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Ivax Pharmaceuticals Main Business
Table 112. Ivax Pharmaceuticals Latest Developments
Table 113. Newtron Pharmaceuticals Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 114. Newtron Pharmaceuticals Brompheniramine Product Portfolios and Specifications
Table 115. Newtron Pharmaceuticals Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Newtron Pharmaceuticals Main Business
Table 117. Newtron Pharmaceuticals Latest Developments
Table 118. Nexgen Pharma Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 119. Nexgen Pharma Brompheniramine Product Portfolios and Specifications
Table 120. Nexgen Pharma Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Nexgen Pharma Main Business
Table 122. Nexgen Pharma Latest Developments
Table 123. Endo International Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 124. Endo International Brompheniramine Product Portfolios and Specifications
Table 125. Endo International Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Endo International Main Business
Table 127. Endo International Latest Developments
Table 128. Novartis Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 129. Novartis Brompheniramine Product Portfolios and Specifications
Table 130. Novartis Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Novartis Main Business
Table 132. Novartis Latest Developments
Table 133. Eon Pharma Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 134. Eon Pharma Brompheniramine Product Portfolios and Specifications
Table 135. Eon Pharma Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Eon Pharma Main Business
Table 137. Eon Pharma Latest Developments
Table 138. Merck Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 139. Merck Brompheniramine Product Portfolios and Specifications
Table 140. Merck Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Merck Main Business
Table 142. Merck Latest Developments
Table 143. Tanta Pharmaceuticals Basic Information, Brompheniramine Manufacturing Base, Sales Area and Its Competitors
Table 144. Tanta Pharmaceuticals Brompheniramine Product Portfolios and Specifications
Table 145. Tanta Pharmaceuticals Brompheniramine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Tanta Pharmaceuticals Main Business
Table 147. Tanta Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Brompheniramine
Figure 2. Brompheniramine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Brompheniramine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Brompheniramine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Brompheniramine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral Solution
Figure 10. Product Picture of Tablet
Figure 11. Global Brompheniramine Sales Market Share by Type in 2022
Figure 12. Global Brompheniramine Revenue Market Share by Type (2018-2023)
Figure 13. Brompheniramine Consumed in Hospital
Figure 14. Global Brompheniramine Market: Hospital (2018-2023) & (K Units)
Figure 15. Brompheniramine Consumed in Drug Store
Figure 16. Global Brompheniramine Market: Drug Store (2018-2023) & (K Units)
Figure 17. Global Brompheniramine Sales Market Share by Application (2022)
Figure 18. Global Brompheniramine Revenue Market Share by Application in 2022
Figure 19. Brompheniramine Sales Market by Company in 2022 (K Units)
Figure 20. Global Brompheniramine Sales Market Share by Company in 2022
Figure 21. Brompheniramine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Brompheniramine Revenue Market Share by Company in 2022
Figure 23. Global Brompheniramine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Brompheniramine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Brompheniramine Sales 2018-2023 (K Units)
Figure 26. Americas Brompheniramine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Brompheniramine Sales 2018-2023 (K Units)
Figure 28. APAC Brompheniramine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Brompheniramine Sales 2018-2023 (K Units)
Figure 30. Europe Brompheniramine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Brompheniramine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Brompheniramine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Brompheniramine Sales Market Share by Country in 2022
Figure 34. Americas Brompheniramine Revenue Market Share by Country in 2022
Figure 35. Americas Brompheniramine Sales Market Share by Type (2018-2023)
Figure 36. Americas Brompheniramine Sales Market Share by Application (2018-2023)
Figure 37. United States Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Brompheniramine Sales Market Share by Region in 2022
Figure 42. APAC Brompheniramine Revenue Market Share by Regions in 2022
Figure 43. APAC Brompheniramine Sales Market Share by Type (2018-2023)
Figure 44. APAC Brompheniramine Sales Market Share by Application (2018-2023)
Figure 45. China Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Brompheniramine Sales Market Share by Country in 2022
Figure 53. Europe Brompheniramine Revenue Market Share by Country in 2022
Figure 54. Europe Brompheniramine Sales Market Share by Type (2018-2023)
Figure 55. Europe Brompheniramine Sales Market Share by Application (2018-2023)
Figure 56. Germany Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Brompheniramine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Brompheniramine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Brompheniramine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Brompheniramine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Brompheniramine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Brompheniramine in 2022
Figure 71. Manufacturing Process Analysis of Brompheniramine
Figure 72. Industry Chain Structure of Brompheniramine
Figure 73. Channels of Distribution
Figure 74. Global Brompheniramine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Brompheniramine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Brompheniramine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Brompheniramine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Brompheniramine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Brompheniramine Revenue Market Share Forecast by Application (2024-2029)